{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:13:51Z","timestamp":1789071231438,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017645","name":"Moorfields Eye Charity","doi-asserted-by":"publisher","award":["GR001376"],"award-info":[{"award-number":["GR001376"]}],"id":[{"id":"10.13039\/501100017645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012617","name":"Moorfields Eye Hospital NHS Foundation Trust","doi-asserted-by":"publisher","award":["NIHR203322"],"award-info":[{"award-number":["NIHR203322"]}],"id":[{"id":"10.13039\/501100012617","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["PGL23\/100048"],"award-info":[{"award-number":["PGL23\/100048"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR301696"],"award-info":[{"award-number":["NIHR301696"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000615","name":"Fight for Sight UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002927","name":"Addenbrooke&apos;s Charitable Trust, Cambridge University Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002927","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.survophthal.2026.04.006","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:48:38Z","timestamp":1777445318000},"page":"1773-1784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Omics in hereditary optic neuropathies: A systematic review of clinical studies with an integrated point of view"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6032-1488","authenticated-orcid":false,"given":"Raoul K.","family":"Khanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Chuen Soong","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Makam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Ducloyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Chao de la Barca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Bocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Vignal-Clermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Orssaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Reynier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Yu-Wai-Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2026.04.006_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101264","article-title":"Mitochondrial retinopathies and optic neuropathies: the impact of retinal imaging on modern understanding of pathogenesis, diagnosis, and management","volume":"101","author":"Borrelli","year":"2024","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.006_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2026.04.006_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100935","article-title":"Dominant optic atrophy: culprit mitochondria in the optic nerve","volume":"83","author":"Lenaers","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.006_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","article-title":"Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies","volume":"30","author":"Yu-Wai-Man","year":"2011","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.006_bib5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/brain\/awac395","article-title":"The top 10 most frequently involved genes in hereditary optic neuropathies in 2186 probands","volume":"146","author":"Rocatcher","year":"2023","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.006_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1474-4422(22)00174-0","article-title":"Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management","volume":"22","author":"Newman","year":"2023","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.04.006_bib7","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1093\/brain\/awad131","article-title":"Autosomal recessive Leber hereditary optic neuropathy, a new neuro-ophthalmo-genetic paradigm","volume":"146","author":"Lenaers","year":"2023","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.survophthal.2026.04.006_bib8","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.ophtha.2009.12.038","article-title":"The prevalence and natural history of dominant optic atrophy due to OPA1 mutations","volume":"117","author":"Yu-Wai-Man","year":"2010","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.006_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/79944","article-title":"OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28","volume":"26","author":"Alexander","year":"2000","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.006_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat Genet"},{"issue":"Pt 3","key":"10.1016\/j.survophthal.2026.04.006_bib11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awq007","article-title":"Multi-system neurological disease is common in patients with OPA1 mutations","volume":"133","author":"Yu-Wai-Man","year":"2010","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.006_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5301\/ejo.5000055","article-title":"Meta-analysis of the prevalence of Leber hereditary optic neuropathy mtDNA mutations in Europe","volume":"22","author":"Mascialino","year":"2012","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.006_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.preteyeres.2006.05.002","article-title":"Leber\u2019s hereditary optic neuropathy: a multifactorial disease","volume":"25","author":"Yen","year":"2006","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.006_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00401-016-1625-2","article-title":"A neurodegenerative perspective on mitochondrial optic neuropathies","volume":"132","author":"Yu-Wai-Man","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.006_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ajhg.2022.11.013","article-title":"Low disease risk and penetrance in Leber hereditary optic neuropathy","volume":"110","author":"Watson","year":"2023","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.survophthal.2026.04.006_bib16","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.ajhg.2021.09.015","article-title":"Establishing risk of vision loss in Leber hereditary optic neuropathy","volume":"108","author":"Lopez Sanchez","year":"2021","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.006_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/WNO.0000000000001367","article-title":"Long-term follow-up after unilateral intravitreal gene therapy for leber hereditary optic neuropathy: the RESTORE study","volume":"41","author":"Biousse","year":"2021","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.006_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40123-022-00611-x","article-title":"Indirect comparison of lenadogene nolparvovec gene therapy versus natural history in patients with leber hereditary optic neuropathy carrying them.11778G>A MT-ND4 mutation","volume":"12","author":"Carelli","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.006_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2025-002164","article-title":"Rasch analysis of the NEI-VFQ-25: vision-related quality of life in Leber hereditary optic neuropathy after lenadogene nolparvovec gene therapy","volume":"10","author":"Chen","year":"2025","journal-title":"BMJ Open Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.006_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/genes12020147","article-title":"From transcriptomics to treatment in inherited optic neuropathies","volume":"12","author":"Gilhooley","year":"2021","journal-title":"Genes"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.006_bib21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/WNO.0000000000001316","article-title":"Cross-sectional analysis of baseline visual parameters in subjects recruited into the RESCUE and REVERSE ND4-LHON gene therapy studies","volume":"41","author":"Moster","year":"2021","journal-title":"J Neuroophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.006_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.survophthal.2024.10.002","article-title":"Meta-analysis of treatment outcomes for patients with m.11778G>A MT-ND4 Leber hereditary optic neuropathy","volume":"70","author":"Newman","year":"2025","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.04.006_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.662838","article-title":"Intravitreal gene therapy vs. natural history in patients with leber hereditary optic neuropathy carrying them.11778G>A ND4 mutation: systematic review and indirect comparison","volume":"12","author":"Newman","year":"2021","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.006_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ophtha.2020.12.012","article-title":"Efficacy and safety of intravitreal gene therapy for leber hereditary optic neuropathy treated within 6 months of disease onset","volume":"128","author":"Newman","year":"2021","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.006_bib25","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/brain\/awac421","article-title":"Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy","volume":"146","author":"Newman","year":"2023","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.006_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40259-021-00468-9","article-title":"Safety of intravitreal gene therapy for treatment of subjects with leber hereditary optic neuropathy due to mutations in the mitochondrial ND4 gene: the REVEAL study","volume":"35","author":"Vignal-Clermont","year":"2021","journal-title":"BioDrugs"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.006_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/jamaophthalmol.2024.5375","article-title":"Five-year outcomes of lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy","volume":"143","author":"Yu-Wai-Man","year":"2025","journal-title":"JAMA Ophthalmol"},{"issue":"573","key":"10.1016\/j.survophthal.2026.04.006_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz7423","article-title":"Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy","volume":"12","author":"Yu-Wai-Man","year":"2020","journal-title":"Sci Transl Med"},{"issue":"22","key":"10.1016\/j.survophthal.2026.04.006_bib29","first-page":"S0039","article-title":"Metabolomics and lipidomics approaches in human tears: a systematic review","author":"Khanna","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.04.006_bib30","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.006_bib31","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/jrsm.1657","article-title":"Critical appraisal tools used in systematic reviews of in vitro cell culture studies: a methodological study","volume":"14","author":"Paiva Barbosa","year":"2023","journal-title":"Res Synth Methods"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.006_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101154","article-title":"Optic atrophy 1 controls human neuronal development by preventing aberrant nuclear DNA methylation","volume":"23","author":"Caglayan","year":"2020","journal-title":"iScience"},{"issue":"9","key":"10.1016\/j.survophthal.2026.04.006_bib33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/hmg\/ddae008","article-title":"OPA1 mutation affects autophagy and triggers senescence in autosomal dominant optic atrophy plus fibroblasts","volume":"33","author":"Zanfardino","year":"2024","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.006_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1167\/iovs.17-23027","article-title":"A plasma metabolomic signature involving purine metabolism in human optic atrophy 1 (OPA1)-related disorders","volume":"59","author":"Bocca","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.006_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-024-01768-1","article-title":"Letter to the editor on: prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume","volume":"12","author":"Bocca","year":"2024","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"10.1016\/j.survophthal.2026.04.006_bib36","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013579","article-title":"High-throughput screening identifies suppressors of mitochondrial fragmentation in OPA1 fibroblasts","volume":"13","author":"Cretin","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"8","key":"10.1016\/j.survophthal.2026.04.006_bib37","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/hmg\/ddaa047","article-title":"Metabolomics hallmarks OPA1 variants correlating with their in vitro phenotype and predicting clinical severity","volume":"29","author":"Chao de la Barca","year":"2020","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.006_bib38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/bjo.2009.165571","article-title":"Genome-wide expression profile of LHON patients with the 11778 mutation","volume":"94","author":"Abu-Amero","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.006_bib39","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/brain\/awh447","article-title":"Isolation of transcriptomal changes attributable to LHON mutations and the cybridization process","volume":"128","author":"Danielson","year":"2005","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.survophthal.2026.04.006_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mito.2006.05.002","article-title":"Mitochondrial disease activates transcripts of the unfolded protein response and cell cycle and inhibits vesicular secretion and oligodendrocyte-specific transcripts","volume":"6","author":"Cortopassi","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.survophthal.2026.04.006_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mito.2020.07.003","article-title":"OXPHOS bioenergetic compensation does not explain disease penetrance in Leber hereditary optic neuropathy","volume":"54","author":"Lopez Sanchez","year":"2020","journal-title":"Mitochondrion"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.006_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.yexcr.2018.01.020","article-title":"Bioactivity and gene expression profiles of hiPSC-generated retinal ganglion cells in MT-ND4 mutated Leber\u2019s hereditary optic neuropathy","volume":"363","author":"Wu","year":"2018","journal-title":"Exp Cell Res"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.006_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/JCMA.0000000000001063","article-title":"Dysregulation of the circRNA_0087207\/miR-548c-3p\/PLSR1-TGFB2 axis in Leber hereditary optic neuropathy in vitro","volume":"87","author":"Yang","year":"2024","journal-title":"J Chin Med Assoc"},{"issue":"1\u20132","key":"10.1016\/j.survophthal.2026.04.006_bib44","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jneuroim.2007.10.004","article-title":"Differential cerebro spinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis","volume":"193","author":"D\u2019Aguanno","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.04.006_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106779","article-title":"Profiling the mitochondrial proteome of Leber\u2019s Hereditary Optic Neuropathy (LHON) in Thailand: down-regulation of bioenergetics and mitochondrial protein quality control pathways in fibroblasts with the 11778G>A mutation","volume":"9","author":"Tun","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.survophthal.2026.04.006_bib46","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3390\/biom12111568","article-title":"Proteomic profiling reveals increased glycolysis, decreased oxidoreductase activity and fatty acid degradation in skin derived fibroblasts from LHON patients bearing m.G11778A","volume":"12","author":"Yao","year":"2022","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.survophthal.2026.04.006_bib47","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3390\/ijms21083027","article-title":"Increased protein S-glutathionylation in leber\u2019s hereditary optic neuropathy (LHON)","volume":"21","author":"Zhou","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.survophthal.2026.04.006_bib48","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/brain\/aww222","article-title":"The metabolomic signature of Leber\u2019s hereditary optic neuropathy reveals endoplasmic reticulum stress","volume":"139","author":"Chao de la Barca","year":"2016","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.006_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11306-018-1345-9","article-title":"NMR metabolomics of fibroblasts with inherited mitochondrial Complex I mutation reveals treatment-reversible lipid and amino acid metabolism alterations","volume":"14","author":"Morvan","year":"2018","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.006_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/hmg\/ddab013","article-title":"A plasma metabolomic signature of Leber hereditary optic neuropathy showing taurine and nicotinamide deficiencies","volume":"30","author":"Bocca","year":"2021","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.survophthal.2026.04.006_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/2441","article-title":"A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)","volume":"20","author":"Inoue","year":"1998","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.survophthal.2026.04.006_bib52","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ana.22160","article-title":"Neurologic features and genotype-phenotype correlation in Wolfram syndrome","volume":"69","author":"Chaussenot","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2026.04.006_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajo.2022.04.003","article-title":"WFS1-associated optic neuropathy: genotype-phenotype correlations and disease progression","volume":"241","author":"Majander","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.006_bib54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40478-024-01851-7","article-title":"A deep phenotyping study in mouse and iPSC models to understand the role of oligodendroglia in optic neuropathy in Wolfram syndrome","volume":"12","author":"Ahuja","year":"2024","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.006_bib55","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1152\/physiolgenomics.00122.2012","article-title":"Silencing of the WFS1 gene in HEK cells induces pathways related to neurodegeneration and mitochondrial damage","volume":"45","author":"K\u00f5ks","year":"2013","journal-title":"Physiol Genom"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.006_bib56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12964-021-00791-2","article-title":"Multiomic analysis on human cell model of wolfram syndrome reveals changes in mitochondrial morphology and function","volume":"19","author":"Zmyslowska","year":"2021","journal-title":"Cell Commun Signal"},{"issue":"11","key":"10.1016\/j.survophthal.2026.04.006_bib57","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1021\/acs.jproteome.7b00401","article-title":"Serum metabolic fingerprinting identified putatively annotated sphinganine isomer as a biomarker of wolfram syndrome","volume":"16","author":"Zmyslowska","year":"2017","journal-title":"J Proteome Res"},{"key":"10.1016\/j.survophthal.2026.04.006_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2022.100900","article-title":"Sphingolipids and their role in health and disease in the central nervous system","volume":"85","author":"Leal","year":"2022","journal-title":"Adv Biol Regul"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.006_bib59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/hmg\/ddab013","article-title":"A plasma metabolomic signature of Leber hereditary optic neuropathy showing taurine and nicotinamide deficiencies","volume":"30","author":"Bocca","year":"2021","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.survophthal.2026.04.006_bib60","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11306-025-02328-x","article-title":"MetabOCT: a clinical trial looking for a metabolomic signature predicting the onset of Leber\u2019s hereditary optic neuropathy in healthy MtDNA mutations carriers","volume":"21","author":"Orssaud","year":"2025","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.survophthal.2026.04.006_bib61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12974-025-03393-8","article-title":"Integration and functionality of human iPSC-derived microglia in a chimeric mouse retinal model","volume":"22","author":"Tang","year":"2025","journal-title":"J Neuroinflamm"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:05:09Z","timestamp":1789070709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625726000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0039625726000597"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.04.006","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omics in hereditary optic neuropathies: A systematic review of clinical studies with an integrated point of view","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}